ChemicalBook > CAS DataBase List > Encainide

Encainide

Product Name
Encainide
CAS No.
37612-13-8
Chemical Name
Encainide
Synonyms
Encainide;Unii-sy3J0147nb;Encainide [inn:ban];Encainide USP/EP/BP;4-Methoxy-N-(2-(2-(1-Methylpiperidin-2-yl)ethyl)phenyl)benzaMide
CBNumber
CB0969673
Molecular Formula
C22H28N2O2
Formula Weight
352.475
MOL File
37612-13-8.mol
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Encainide Chemical Properties,Usage,Production

Description

Encainide is a membrane-active class I c agent with complex metabolism and clinical pharmacology , . To date, its effectiveness has been proved against ventricular arrhythmias.

Uses

Cardiac depressant (anti-arrhythmic.

Uses

Clinical use of encainide is primarily associated with the presence of serious ventricular tachycardia; however, like flecainide, it is also sufficiently effective for atrial arrhythmia and is used for natural occurrences.

Definition

ChEBI: Encainide is 4-Methoxy-N-phenylbenzamide in which the hydrogen at the 2 position of the phenyl group is substituted by a 2-(1-methylpiperidin-2-yl)ethyl group. A class Ic antiarrhythmic, the hydrochloride was used for the treatment of severe or life-threatening ventricular arrhythmias, but it was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack and was withdrawn from the market. It has a role as an anti-arrhythmia drug and a sodium channel blocker. It is a member of piperidines and a member of benzamides.

brand name

Enkaid (Bristol Labs).

World Health Organization (WHO)

The membrane-stabilizing antiarrhythmic agent encainide was introduced into medicine in the mid-1980's. The decision to delete the indications for patients with asymptomatic and less severe symptomatic ventricular arrhythmias was taken on the basis of the results of a trial (CAST study) that showed a two-fold increase in deaths in post-myocardiac patients taking encainide compared with the placebo group. (See also WHO comment for flecainide).

Side effects

Side effects include central nervous system activity.

Synthesis

Encainide, 4-methoxy-N-[2-[2-(1-methyl-2-piperidinyl)ethyl]phenyl]-benzamide (18.1.15), is synthesized by acylating 2-(1-methyl-2-piperidylethyl)aniline with 4- methoxybenzoic acid chloride. The chemical structure of encainide is substantially different than other local anesthetics and antiarrhythmics.

Encainide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Encainide Suppliers

Shaanxi Dideu Medichem Co. Ltd
Tel
+86-029-89586680 +86-18192503167
Fax
+86-29-88380327
Email
1026@dideu.com
Country
China
ProdList
9456
Advantage
58
Career Henan Chemica Co
Tel
+86-0371-86658258 15093356674;
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30255
Advantage
58
Alchem Pharmtech,Inc.
Tel
8485655694
Email
sales@alchempharmtech.com
Country
United States
ProdList
63711
Advantage
58
ZHEJIANG JIUZHOU CHEM CO., LTD
Tel
+86-0576225566889 +86-13454675544
Email
admin@jiuzhou-chem.com;jamie@jiuzhou-chem.com;alice@jiuzhou-chem.com
Country
China
ProdList
20000
Advantage
58

37612-13-8, EncainideRelated Search:


  • Encainide
  • Encainide [inn:ban]
  • Unii-sy3J0147nb
  • 4-Methoxy-N-(2-(2-(1-Methylpiperidin-2-yl)ethyl)phenyl)benzaMide
  • Encainide USP/EP/BP
  • 37612-13-8